Insulin regimens and clinical outcomes in a type 1 diabetes cohort: The SEARCH for diabetes in youth study

Diabetes Care

Volumn 36, Issue 1, 2013, Pages 27-33

  Pihoker, Catherine ^a   Badaru, Angela ^a   Anderson, Andrea ^b   Morgan, Timothy ^b   Dolan, Lawrence ^c   Dabelea, Dana ^d   Imperatore, Giuseppina ^e   Linder, Barbara ^f   Marcovina, Santica ^g   Mayer Davis, Elizabeth ^h   Reynolds, Kristi ⁱ   Klingensmith, Georgeanna J ^j  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Department of Civil and Environmental Engineering at Colorado State University and the Department of Environmental and Occupational Health at the Colorado School of Public Health   (United States)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ NONE   (United States)

^j UNIVERSITY OF COLORADO DENVER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; SHORT ACTING INSULIN;

AGE; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; SCHOOL CHILD; SELF CARE; SELF MONITORING; SOCIAL STATUS; TREATMENT PLANNING;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; TREATMENT OUTCOME;

EID: 84872034557     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0720     Document Type: Article

References (15)

1. Rubin RR, Peyrot M. Implications of the DCCT. Looking beyond tight control. Diabetes Care 1994;17:235-236
2. Cleary PA, Orchard TJ, Genuth S, et al.; DCCT/EDIC Research Group. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 2006;55:3556-3565 (Pubitemid 44923617)
3. Silverstein J, Klingensmith G, Copeland K, et al.; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28:186-212 (Pubitemid 40095803)
4. de Beaufort CE, Swift PG, Skinner CT, et al.; Hvidoere Study Group on Childhood Diabetes 2005. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 2007;30:2245-2250 (Pubitemid 47359026)
5. Haller MJ, Silverstein JH. In pursuit of lower A1c. J Pediatr 2009;155:161-162
6. Paris CA, Imperatore G, Klingensmith G, et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr 2009;155:183-189
7. Ludvigsson J; Linköping Diabetes Immune Intervention Study Group. The role of immunomodulation therapy in autoimmune diabetes. J Diabetes Sci Tech 2009;3:320-330
8. Herold KC, Gitelman S, Greenbaum C, et al.; Immune Tolerance Network ITN007AI Study Group. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol 2009;132:166-173
9. SEARCH Study Group. SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471
10. Ingram DD, Parker JD, Schenker N, et al. United States Census 2000 population with bridged race categories. Vital Health Stat 2 2003;135:1-55
11. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002;246:1-190
12. Beck JK, Lewis TV, Logan KJ, Harrison DL, Gardner AW, Copeland KC. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: should payer source influence the choice of therapy? Pediatr Diabetes 2009;10:368-373
13. Helgeson VS, Honcharuk E, Becker D, Escobar O, Siminerio L. A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency. Pediatr Diabetes 2011;12:25-30
14. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R; DPV-Wiss-Initiative. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011;12:11-17
15. Liese AD, Liu L, Davis C, et al. Participation in pediatric epidemiologic research: the SEARCH for Diabetes in Youth Study experience. Contemp Clin Trials 2008;29:829-836